• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Prana Biotechnology Ltd

+ Add to Watchlist

PBNA:GR

1.236 EUR 0.025 1.98%

As of 09:57:12 ET on 04/16/2014.

Snapshot for Prana Biotechnology Ltd (PBNA)

Open: 1.200 Day's Range: 1.200 - 1.302 Volume: 719
Previous Close: 1.261 52wk Range: 1.200 - 8.900 1-Yr Rtn: -26.12%

Stock Chart for PBNA

No chart data available.
  • PBNA:GR 1.236
  • 1D
  • 1M
  • 1Y
1.261
Interactive PBNA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PBNA

Current P/E Ratio (ttm) -
Estimated P/E(06/2014) -
Relative P/E vs. DAX -
Earnings Per Share (AUD) (ttm) -
Est. EPS (AUD) (06/2014) -0.1340
Est. PEG Ratio -
Market Cap (M EUR) 60.40
Shares Outstanding (M) 48.86
30 Day Average Volume 1,962
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 09/01/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PBNA

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for PBNA

Prana Biotechnology Limited is an Australian biotechnology company which researches and develops therapeutic drugs used for treatment of Alzheimer's Disease and other age-related degenerative disorders such as Parkinson's Disease and cataracts.

Geoffrey P KemplerChairman/CEO/FounderRichard RevelinsCFO/Secretary
Diane AngusChief Operating OfficerRudolph E Tanzi "Rudy"Chief Scientific Advisor
More Company Profile & Key Executives for PBNA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil